The clinical effectiveness of baloxavir marboxil in treating influenza A(H1N1)pdm09, A(H3N2), and B and the emergence of PA variants that confer reduced susceptibility.

Yoshihiro Kawaoka, D.V.M., PhD

Professor, The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center

Director, The Research Center for Global Viral Diseases National Center for Global Health and Medicine

Reiko Saito, MD, PhD

Professor, Departmental Head Division of International Health, Graduate School of Medical and Dental Science,Niigata University,Niigata City,Japan

Banquet Room Daigo Sheraton Miyako Hotel Tokyo

1-1-50 Shirokanedai, Minato-ku, Tokyo